AspirinThromboxane A2Receptors, ThromboxaneReceptors, Thromboxane A2, Prostaglandin H2ThromboxanesThromboxane-A SynthasePlatelet Aggregation Inhibitors15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidProstaglandin Endoperoxides, SyntheticPlatelet AggregationAnti-Inflammatory Agents, Non-SteroidalBlood Platelets6-Ketoprostaglandin F1 alphaCyclooxygenase InhibitorsHydrazinesEpoprostenolProstaglandins HProstaglandinsReceptors, ProstaglandinTiclopidineProstaglandin EndoperoxidesThromboxane B2Prostaglandin H2Prostaglandin-Endoperoxide SynthasesSalicylatesCyclooxygenase 1IndomethacinPlatelet Function TestsBleeding TimeArachidonic AcidArachidonic AcidsEicosanoidsIbuprofenDinoprostonePentanoic AcidsDose-Response Relationship, DrugDrug Therapy, CombinationCyclooxygenase 2BenzoxepinsMethacrylatesProstaglandins EFibrinolytic AgentsProstanoic AcidsCyclooxygenase 2 InhibitorsVasoconstrictor AgentsSodium SalicylateProstaglandin AntagonistsProstaglandins, SyntheticHemorrhageDinoprostProstaglandins DThrombosisAsthma, Aspirin-InducedVasoconstrictionAdenosine DiphosphateProstaglandins FAnticoagulantsWarfarinTablets, Enteric-CoatedDouble-Blind Methodbeta-ThromboglobulinImidazolesGastrointestinal HemorrhagePlatelet ActivationLipoxinsDipyridamoleSulfinpyrazoneSulfonamidesNaproxenTime FactorsDrug ResistanceAcrylatesGastric MucosaSRS-ABicyclo CompoundsMyocardial InfarctionIsoprostanesDrug InteractionsAcetaminophenRisk FactorsThrombinStomach UlcerEicosanoic AcidsPlatelet CountBiphenyl CompoundsTreatment OutcomeRabbitsPlatelet Glycoprotein GPIIb-IIIa ComplexProspective StudiesReye SyndromeStrokeCollagenEndothelium, VascularHeparin